NCT04707625: Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment |
|
|
| Terminated | 4 | 17 | US | Aflibercept Ophthalmic, Eylea | Wake Forest University Health Sciences | Retinal Vein Occlusion | 12/23 | 12/23 | | |
NCT04075136: Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy |
|
|
| Withdrawn | 4 | 150 | US | Ranibizumab, Lucentis, Photodynamic laser treatment (PDT), Triamcinolone Acetonide, Triesence, verteporfin, Visudyne | Wake Forest University Health Sciences, Modulight | Exudative Age Related Macular Degeneration | 11/24 | 12/24 | | |
| Active, not recruiting | 4 | 9971 | RoW | Atorvastatin, Lipitor, , , Cadivast, Caduet, Lorstat, Torvastat, Trovas, Atorachol, Cadatin, Placebo (for Atorvastatin), no other names | Monash University, National Health and Medical Research Council, Australia, National Heart Foundation, Australia | Independent Living, Disability Free Survival, Elderly, Healthy | 12/25 | 12/25 | | |